:

Xiang Zhang1, Cheng Zhang2, Zheng Zhang3

  • 1School of Anesthesiology, Wannan Medical College, Wuhu, Anhui, China.

Frontiers in immunology
|August 29, 2025
PubMed
概括

外体是肝细胞癌 (HCC) 进展的关键因素,驱动药物耐药性和转移. 工程外体具有针对性肝癌治疗的潜力,但临床应用仍然存在挑战.